Torigen Pharmaceuticals

company

About

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$13M
Industries
Biotechnology,Health Care,Veterinary
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals. They strive to bring novel approaches to the market to tackle companion animal cancers, building on years of existing scientific research and pushing the boundaries of innovation.

The company was founded in 2013 by Ashley Kalinauskas and Mark Suckow and is based in Farmington, Connecticut, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$13M
Torigen Pharmaceuticals has raised a total of $13M in funding over 2 rounds. Their latest funding was raised on Nov 16, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 16, 2022 Series A $13M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Torigen Pharmaceuticals is funded by 2 investors. Advantage Capital and Gaingels are the most recent investors.
Investor Name Lead Investor Funding Round
Advantage Capital Series A
Gaingels Series A